title: Reply to the letter to the editor 'A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma' by Hines et al.
authors.affiliation: Department of Oncology, Ospedale San Carlo, Potenza.
authors.forename: G
authors.initials: G
authors.lastname: Rosati
authors.affiliation: Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan.
authors.forename: P
authors.initials: P
authors.lastname: Mosconi
authors.affiliation: Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan.
authors.forename: V
authors.initials: V
authors.lastname: Torri
authors.affiliation: Department of Oncology, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Apolone
authors.affiliation: Department of Surgery, St Louis University Hospital, St Louis, USA.
authors.forename: F E
authors.initials: FE
authors.lastname: Johnson
authors.affiliation: Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan. Electronic address: roldano.fossati@marionegri.it.
authors.forename: R
authors.initials: R
authors.lastname: Fossati
mesh_terms: D002272:Carcinoembryonic Antigen; D003110:Colonic Neoplasms; D015179:Colorectal Neoplasms; D006801:Humans
chemical_list: D002272:Carcinoembryonic Antigen